Revaprazan
CAS: 199463-33-7
Ref. 3D-ZHA46333
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Revaprazan
Sinónimos:
- 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine
- YH 1885 free base
- 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-
- SB 641257
Descripción:
Revaprazan hydrochloride is the salt form of Revaprazan which is concentrated in the gastric parietal cell canaliculus. Due to the acidic environment of the parietal cells, Revaprazan is protonated and binds to and reversibly inhibits H+/K+-ATPase. As a result H+ ions are prevented from entering into the gastric lumen, thus hindering the production of gastric acid. This ability of Revaprazan has enabled it to be used to treat gastric ulcers and gastroesophageal reflux disease. According to the biopharmaceutical classification system, Revaprazan is a class II drug, however it has low oral bioavailability.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
362.4 g/mol
Fórmula:
C22H23FN4
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
